Our Sole Focus: Human Therapeutic Antibody Discovery

We understand how to position your discovery program for success while navigating through potential pitfalls, because we have years of experience in generation of therapeutic-quality antibodies from rodents, both wild-type and transgenic.

We work with companies large and small, ranging from companies operating virtually to established companies wanting to enhance their existing capabilities.

Our team of experts will become your team of experts, creating a tailored therapeutic discovery project.

Leadership

Board of Directors

Meet Your Team

James Graziano, Ph.D.

James Graziano, Ph.D. >

Senior Director, Operations

Maya Tanaka

Maya Tanaka >

Senior Director, Business Development

Dana Duey

Dana Duey >

Associate Director, Antibody Discovery

Jacek Ostrowski, Ph.D.

Jacek Ostrowski, Ph.D. >

Associate Director, Protein Chemistry

Ritsuko Sawada, Ph.D.

Ritsuko Sawada, Ph.D. >

Senior Scientist

Shea Grenier

Shea Grenier >

Research Associate II

Crystal Bantados

Crystal Bantados >

Senior Project Manager

Matthew Hsu, Ph.D.

Matthew Hsu, Ph.D. >

Senior Scientist

Our Relationship with Ablexis

We use the AlivaMab Mouse, developed by Ablexis, LLC, as the platform for your discovery project. Chosen by many leading pharmaceutical companies, this best-in-class transgenic platform generates human therapeutic antibody candidates with high potency, specificity, developability qualities and reduced chances of immunogenicity.

We founded AlivaMab Discovery Services after hearing the needs of many prospective partners wanting to outsource discovery to a scientifically-driven organization led by a team with in-the-trenches experience and real understanding of therapeutic antibody discovery and development.

To learn more visit www.ablexis.com

AllivaMab Mouse